Natural history of changes in prostate specific antigen in early stage prostate cancer

Journal of Urology

Volumn 152, Issue 5 II, 1994, Pages 1743-1748

  Pearson, J D ^a   Carter, H B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

neoplasm invasiveness; neoplasm metastasis; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONFERENCE PAPER; DRUG BLOOD LEVEL; EARLY DIAGNOSIS; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0028149338     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(17)32375-3     Document Type: Conference Paper

References (31)

1. J.S. Meyer G. Sufrin S.A. Martin Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling J. Urol. 128 1982 1353
2. P.R. Carroll F.M. Waldman W. Rosenau M.B. Cohen J.M. Vapnek P. Fong P. Narayan B.H. Mayall Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression J. Urol. 149 1993 403
3. J.E. McNeal D.G. Bostwick R.A. Kindrachuk E.A. Redwine F.S. Freiha T.A. Stamey Patterns of progression in prostate cancer Lancet 1 1986 60
4. J.E. McNeal A.A. Villers E.A. Redwine F.S. Freiha T.A. Stamey Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate Cancer 66 1990 1225
5. A.S. Whittemore J.B. Keller R. Betensky Low-grade, latent prostate cancer volume: predictor of clinical cancer incidence? J. Natl. Cancer Inst. 83 1991 1231
6. W.F. Whitmore J.A. Warner I.M. Thompson Jr. Expectant management of localized prostatic cancer Cancer 67 1991 1091
7. J. Adolfsson J. Carstensen Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old J. Urol. 146 1991 96
8. J.-E. Johansson H.-O. Adami S.-O. Andersson R. Bergstrom U.B. Krusemo W. Kraaz Natural history of localized prostatic cancer. A population-based study in 223 untreated patients Lancet 1 1989 799
9. J.-E. Johansson H.-O. Adami S.-O. Andersson R. Bergstrom L. Holmberg U.B. Krusemo High 10-year survival rate in patients with early, untreated prostatic cancer J.A.M.A. 267 1992 2191
10. J.P. Weber J.E. Oesterling C.A. Peters A.W. Partin D.W. Chan P.C. Walsh The influence of reversible androgen deprivation on serum prostate specific antigen levels in men with benign prostatic hyperplasia J. Urol. 141 1989 987
11. A.W. Partin H.B. Carter D.W. Chan J.I. Epstein J.E. Oesterling R.C. Rock J.P. Weber P.C. Walsh Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia J. Urol. 143 1990 747
12. H.B. Carter J.D. Pearson E.J. Metter L.J. Brant D.W. Chan R. Andres J.L. Fozard P.C. Walsh Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease J.A.M.A. 267 1992 2215
13. H.B. Carter C.H. Morrell J.D. Pearson L.J. Brant C.C. Plato E.J. Metter D.W. Chan J.L. Fozard P.C. Walsh Estimation of prostatic growth using serial prostate specific antigen measurements in men with and without prostate disease Cancer Res. 52 1992 3323
14. J.A. Cadeddu J.D. Pearson A.W. Partin J.I. Epstein H.B. Carter Relationship between changes in prostate-specific antigen and prognosis of men with prostate cancer Urology 42 1993 383
15. N.W. Shock R.C. Greulich R. Andres D. Arenberg P.T. Costa E.G. Lakatta J.D. Tobin Normal Human Aging: The Baltimore Longitudinal Study of Aging publication No. 84-2450 1984 National Institutes of Health Washington, D. C.
16. J.D. Pearson C.H. Morrell P.K. Landis H.B. Carter L.J. Brant Mixed-effects regression models for studying the natural history of prostate disease Stat. Med. 13 1994 587
17. N. Kyprianou P. Martikainen J.T. Isaacs Programmed cell death of normal and malignant prostatic cells K.D. Voigt C. Knabbe Endocrine Dependent Tumors 1991 Raven Press New York 69 81
18. S.J. Berry D.S. Coffey P.C. Walsh L.L. Ewing The development of human benign prostatic hyperplasia with age J. Urol. 132 1984 474
19. J. McNeal Pathology of benign prostatic hyperplasia: insight into etiology Urol. Clin. N. Amer. 17 1990 477
20. T.A. Stamey N. Yang A.R. Hay J.E. McNeal F.S. Frieha E.A. Redwine Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate New Engl. J. Med. 317 1987 909
21. K. Mandell A. Partin G. Hill J. Epstein R. Stutzman H.B. Carter P. Walsh PSA density in BPH: correlation with stromal epithelial ratios and influence of age abstract 943 J. Urol. 149 part 2 1993 448A abstract 943
22. H. Jacobsen S. Torp-Pedersen N. Juul Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia Scand. J. Urol. Nephrol. 107 suppl. 1988 26
23. H.B. Carter S. Piantadosi J.T. Isaacs Clinical evidence for and implications of the multistep development of prostate cancer J. Urol. 143 1990 742
24. J.T. Isaacs N. Wake D.S. Coffey A.A. Sandberg Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system Cancer Res. 42 1982 2353
25. M.E. Gleave J. Hsieh H. Wu A.C. von Eschenback L.W.K. Chung Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors Cancer Res. 52 1992 1598
26. T.A. Stamey J.N. Kabalin Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients J. Urol. 141 1989 1070
27. H.P. Schmid J.E. McNeal T.A. Stamey Observations on the doubling time of prostate cancer: the use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume Cancer 71 1992 2031
28. W.J. Catalona D.S. Smith T.L. Ratliff K.M. Dodds D.E. Coplen J.J. Yuan J.A. Petros G.L. Andriole Measurement of prostate-specific antigen in serum as a screening test for prostate cancer New Engl. J. Med. 324 1991 1156
29. H.B. Carter A.W. Partin J.I. Epstein P.C. Walsh Relationship between PSA and residual tumor volume in stage A prostate cancer J. Urol. 144 1990 1167
30. D.E. Neal Jr. S. Clejan D. Sarma T.D. Moon Prostate specific antigen and prostatitis I: effect of prostatitis on serum PSA in the human and nonhuman primate Prostate 20 1992 105
31. A.W. Partin J.I. Epstein K.R. Cho A.M. Gittelsohn P.C. Walsh Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer J. Urol. 141 1989 341